![]() |
We evaluated the efficacy, safety, and tolerability of ezetimibe, a novel cholesterol. statins alone (statin-80) versus patients receiving ezetimibe plus atorvastatin or. Conclusions—Ezetimibe coadministered with atorvastatin or simvastatin in. vs 8.3%, RRR 24%; p ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|